Brief: Recro Announces Amendment To Athyrium Credit Facility
Feb 23 (Reuters) - Recro Pharma Inc REPH.O :
* RECRO ANNOUNCES AMENDMENT TO ATHYRIUM CREDIT FACILITY
* RECRO PHARMA INC - CREDIT FACILITY'S OUTSTANDING DEBT
BALANCE
HAS BEEN REDUCED FROM $116 MILLION TO $100 MILLION
* RECRO PHARMA INC - INTEREST RATE GOVERNING FACILITY HAS
BEEN
DECREASED BY 1.5 PERCENT
* RECRO PHARMA INC - THERE WILL BE NO ADDITIONAL PRINCIPAL
AMORTIZATION DURING REMAINDER OF TERM OF FACILITY, WHICH RUNS
THROUGH MARCH 2023
Source text for Eikon: ID:nGNX5CClfd
Further company coverage: REPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Societal CDMO
See all newsBrief: Corerx Inc Completes Acquisition Of Societal CDMO Inc
Societal CDMO Inc reports results for the quarter ended in December - Earnings Summary
Brief: Societal CDMO Inc Received Notice From Nasdaq Stating Co Regained Compliance With Nasdaq Listing Rule 5550(A)(2) On March 14
Brief: Societal Cdmo Enters Into Definitive Agreement To Be Acquired By Corerx, Inc.
Societal CDMO Inc expected to post a loss of 1 cent a share - Earnings Preview